OpenAlex
PricingAboutJobs
Log inGet started
Work

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

HTML

Year: 2020
Type: article
Study design: Observational Study
Source: Psychotherapy and Psychosomatics
DOI: 10.1159/000510703
Authors: Chiara Gastaldon, Emanuel Raschi, John M. Kane, Corrado Barbui, Georgios Schoretsanitis
Institutions: University of Verona, Northwell Health, Zucker Hillside Hospital, University of Bologna, Feinstein Institute for Medical Research, Hofstra University, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions
Subfield: Toxicology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: esketamine, treatment-resistant depression, post-marketing safety, adverse event signals, dissociation, sedation, suicidal ideation, suicide mortality, venlafaxine, mood stabilizers, FDA Adverse Event Reporting System, reporting odds ratio, information component, serious adverse events, sex differences in adverse events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3082360571
FWCI: 10.2
Cites: 54
Cited by: 143
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security